• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Consumer Cyclical·603335.SS
Share

Guangdong Dcenti Auto-Parts Stock Limited Company Stocks

CN¥ 6.29Last Updated 16.07.2026

Issuer Rating

2/7
Performance

Poor

Risk

Moderate

Recommendation

Sell

Market Cap

CN¥ 449.25M

CN¥ 6.29
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1999 and based in Taishan, China, Guangdong Dcenti Auto-Parts Stock Limited Company operates as an enterprise dedicated to the research, development, production, and distribution of automotive components. The company's core business involves manufacturing and supplying aluminum alloy wheels, which it sells to chain stores across China and also exports internationally. Its product portfolio features a diverse array of wheels, including the STW, LM, and DCTL models under the DCENTI brand; Borghini, Red Sport, U2, Velocity, and GIMA wheels as part of the Velocity series; and RDR wheels within the RDR series. Previously known as Stonewell International Corporation, the company adopted its current name in July 2014.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.07.2026 11:26

Software developers are under fire once again. Which companies in the sector are worth investing in?

17.07.2026 10:51

SpaceX canceled the Starship launch due to engine problems. The stock price fell again.

17.07.2026 10:35

Top Stories This Morning: SpaceX Cancels Starship Launch; Tech Stocks Under Pressure

17.07.2026 09:30

Berkshire Hathaway may have accelerated its share buyback. This was indicated in Buffett's documents

17.07.2026 08:30

Lilly to Acquire Psychedelic Drug Developer for $3.8 Billion. Are There Any Prospects?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026